Around 41% of UK employees believe their employer should cover weight-management drugs in workplace healthcare plans, Howden Employee Benefits has found.
According to the broking group's report, Changing Face of Employee Health, 26% of UK employees have already used one type of blockbuster GLP-1 weight-management drug such as Ozempic. Howden said this is putting pressure on businesses to reconsider their approach to employee health, with 44% of employers to redo their healthcare plans to meet evolving employee needs. However, balancing the financial cost of this is reportedly creating new challenges for businesses; the increase in usage of these drugs has meant that 50% of UK businesses covering weight-management drugs now view them as...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.




